mepacrine hydrochloride
CLINICAL USE
Giardiasis Discoid lupus erythematosus
DOSE IN NORMAL RENAL FUNCTION
100 mg every 8 hours for 5–7 days
PHARMACOKINETICS
Molecular weight                           :508.9 %Protein binding                           :80–90 %Excreted unchanged in urine     : <11 Volume of distribution (L/kg)       :Largehalf-life – normal/ESRD (hrs)      :5–14 days DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unlikely to be dialysed. Dose as in normal renal function HD                     :Unlikely to be dialysed. Dose as in normal renal functionHDF/high flux   :Unlikely to be dialysed. Dose as in normal renal functionCAV/VVHD      :Unlikely to be dialysed. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAlcohol: can cause a mild disulfiram reactionAntimalarials: increased concentration of primaquine (increased risk of toxicity) ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
–Comments
– OTHER INFORMATION
Still detectable in the urine after 2 months
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home